MR Imaging-Transrectal US Fusion for Targeted Prostate Biopsies: Implications for Diagnosis and Clinical Management.
暂无分享,去创建一个
Ivan Pedrosa | Neil M Rofsky | C. Roehrborn | N. Rofsky | I. Pedrosa | Daniel N Costa | Francisco Donato | Claus G Roehrborn | Daniel N. Costa | F. Donato
[1] François Cornud,et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.
[2] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[3] P. Mozer,et al. TRUS–MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer , 2013, Abdominal Imaging.
[4] Thomas Hambrock,et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.
[5] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[6] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[7] K. Wallner,et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.
[8] Herbert Y. Kressel,et al. Prostatic carcinoma: staging with MR imaging at 1.5 T. , 1988 .
[9] F. Aragona,et al. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. , 2007, Urology.
[10] D. Chan,et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.
[11] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[12] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[13] Jocelyne Troccaz,et al. Mapping of Transrectal Ultrasonographic Prostate Biopsies , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[14] Karla Kerlikowske,et al. Performance benchmarks for screening mammography. , 2006, Radiology.
[15] P. Carroll,et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.
[16] A. Villers,et al. Target ablation--image-guided therapy in prostate cancer. , 2014, Urologic oncology.
[17] Clare Allen,et al. Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.
[18] Purang Abolmaesumi,et al. Experimental validation of an intrasubject elastic registration algorithm for dynamic-3D ultrasound images. , 2012, Medical physics.
[19] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[20] Ivan Pedrosa,et al. Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. , 2013, Magnetic resonance imaging.
[21] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[22] I. Thompson,et al. Active surveillance for prostate cancer. , 2010, JAMA.
[23] Laurent Lemaitre,et al. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance , 2009, Current opinion in urology.
[24] P. Choyke,et al. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. , 2010, The Journal of urology.
[25] Jurgen J Fütterer,et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.
[26] Monish Aron,et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. , 2012, The Journal of urology.
[27] Pingkun Yan,et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.
[28] Yair Lotan,et al. Systematic review of complications of prostate biopsy. , 2013, European urology.
[29] Shyam Natarajan,et al. MRI–ultrasound fusion for guidance of targeted prostate biopsy , 2013, Current opinion in urology.
[30] Murray Krahn,et al. Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome , 2006 .
[31] Brian R Matlaga,et al. Prostate biopsy: indications and technique. , 2003, The Journal of urology.
[32] H M Pollack,et al. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. , 1993, The Journal of urology.
[33] A W Partin,et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.
[34] H. Ahmed,et al. Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies , 2014, Current Urology Reports.
[35] R. Hoffman,et al. Clinical practice. Screening for prostate cancer. , 2011, The New England journal of medicine.
[36] Zeike A. Taylor,et al. MR to ultrasound registration for image-guided prostate interventions , 2012, Medical Image Anal..
[37] Christopher R King,et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. , 2004, International journal of radiation oncology, biology, physics.
[38] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[39] M. Cooperberg,et al. The changing face of prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] F. Beuvon,et al. Value of Multiparametric MRI in the Work-up of Prostate Cancer , 2012, Current Urology Reports.
[41] P. Mozer,et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.
[42] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[43] P. Puppo. Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. , 2007, European urology.
[44] Thomas M. Wheeler,et al. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .
[45] J R Thornbury,et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.
[46] C. Moore,et al. MRI-targeted prostate biopsy: a review of technique and results , 2013, Nature Reviews Urology.
[47] A. Padhani,et al. Multiparametric imaging of tumor response to therapy. , 2010, Radiology.
[48] J. Epstein,et al. Letters to the Editor/Errata Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails , 2010 .
[49] Shyam Natarajan,et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.
[50] J. Presti,et al. Prostate biopsy: current status and limitations. , 2007, Reviews in urology.
[51] Baris Turkbey,et al. Documenting the location of prostate biopsies with image fusion , 2011, BJU international.
[52] Yousef Mazaheri,et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. , 2014, Radiology.
[53] E J Halpern,et al. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. , 2000, AJR. American journal of roentgenology.
[54] L. Klotz. Active surveillance for prostate cancer: for whom? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] A. Hoznek,et al. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria? , 2010, The Journal of urology.
[56] Matthew R Cooperberg,et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.